Maynard Ryan D — SEC Form 4 filings
SEC reporting owner CIK 1363984. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-05 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 55,488 shares, $505,909 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 50,000 shares @ $10.06 ($503,000) in IOVANCE BIOTHERAPEUTICS, INC., filed 2024-11-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Director | 5 | — | 1 leg · 50,000 sh · $503,000 | 6 |
| Cara Therapeutics, Inc. (CARA) | CHIEF FINANCIAL OFFICER | 2 | — | 1 leg · 5,488 sh · $2,909 | 1 |
| Foghorn Therapeutics Inc. (FHTX) | Chief Financial Officer | 1 | — | — | 1 |
Form 4 filings — Maynard Ryan D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 90,316 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 400,000 (derivative) @ $5.75 | EDGAR |
| 2025-06-17 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 67,546 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 50,000 @ $7.45 · Sale (S): 50,000 @ $10.06 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 49,303 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 5,488 @ $0.53 | EDGAR |
| 2024-02-05 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 13,500 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1363984 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →